Objective: A significant proportion of the more than 50 million people worldwide currently suffering with epilepsy are resistant to antiepileptic drugs (AEDs). As an alternative to AEDs, novel therapies based on cell transplantation offer an opportunity for long-lasting modification of epileptic circuits. To develop such a treatment requires careful preclinical studies in a chronic epilepsy model featuring unprovoked seizures, hippocampal histopathology, and behavioral comorbidities. Methods: Transplantation of progenitor cells from embryonic medial or caudal ganglionic eminence (MGE, CGE) were made in a well-characterized mouse model of status epilepticus-induced epilepsy (systemic pilocarpine). Behavioral testing (handling and open field), continuous video-electroencephalographic (vEEG) monitoring, and slice electrophysiology outcomes were obtained up to 270 days after transplantation (DAT). Post-hoc immunohistochemistry was used to confirm cell identity. Results: MGE progenitors transplanted into the hippocampus of epileptic mice rescued handling and open field deficits starting at 60 DAT. In these same mice, an 84% to 88% reduction in seizure activity was observed between 180 and 210 DAT. Inhibitory postsynaptic current frequency, measured on pyramidal neurons in acute hippocampal slices at 270 DAT, was reduced in epileptic mice but restored to na€ ıve levels in epileptic mice receiving MGE transplants. No reduction in seizure activity was observed in epileptic mice receiving intrahippocampal CGE progenitors.
pilepsy is a spectrum of neurological disorders with heterogeneous origins characterized by unprovoked seizures, as well as behavioral and cognitive comorbidities. Available epilepsy treatments include antiepileptic drugs (AEDs), which provide pharmacological modulation of receptors (N-methyl-D-aspartate, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and gammaaminobutyric acid [GABA] ) or ion channels (Na 1 and Ca 11 ), 1 vagal nerve stimulation, 2 or surgical resection. 3 Unfortunately, therapies are associated with side effects and nearly one third of all epilepsy patients remain refractory.
Interneurons are specialized cells in the central nervous system that release an inhibitory neurotransmitter (GABA) and share a common embryonic origin in medial and caudal ganglionic eminences (MGE and CGE, respectively). [4] [5] [6] In acquired and genetic forms of epilepsy, inhibitory interneuron loss or dysfunction has been reported. [7] [8] [9] Because embryonic interneuron progenitor cells migrate following transplantation, 10-13 they offer a potentially exploitable cell source for an interneuron-based cell therapy. Transplanted MGEderived cells integrate and exhibit mature electrophysiological properties consistent with fast-spiking parvalbumin (PV)-positive and regular-spiking somatostatin (SOM)-positive interneuron subtypes. 11, 14, 15 MGEderived interneurons receive subtype appropriate functional excitatory synaptic inputs from host brain neurons, 11, 16 and synaptic contacts between transplantderived interneurons and host neurons have been
View this article online at wileyonlinelibrary.com. DOI: 10.1002/ana.25021 observed using electron microscopy, 17 optogenetics, 13, 18, 19 and dual recordings. 16, 20 Most important, MGE-derived interneurons appear to selectively innervate excitatory neurons, resulting in functional enhancement of GABAmediated synaptic inhibition. 11, [15] [16] [17] 19, 21 CGE-derived interneurons can also migrate following transplantation, differentiate to vasoactive intestinal polypeptide (VIP)-and reelin-positive interneurons, and make functional inhibitory connections onto either pyramidal cells or inhibitory interneurons. 22, 23 MGE progenitor transplantation was first shown to suppress unprovoked seizures in a potassium channel mutant mouse (Kv1.1), representing an ion channel mutation associated with severe tonic-clonic seizures in humans. 17 Starting at 30 days after transplantation (DAT), video-electroencephalographic (vEEG) monitoring demonstrated a 90% reduction in seizure frequency in these mice. Using a well-characterized pilocarpine model of acquired epilepsy, we also demonstrated that MGE progenitors transplanted into adult hippocampus reduced unprovoked seizures by 90% starting at 60 DAT. 14 Whereas our studies strongly support continued preclinical development of MGE progenitor transplantation as a therapy for intractable epilepsies, other groups suggested that these effects may be transient 18, 24, 25 and CGE-based cell transplantation for epilepsy has not been studied.
To address discrepancies, and provide a more complete understanding of interneuron subpopulations that could be used for therapeutic purposes, we transplanted embryonic mouse MGE or CGE progenitors into pilocarpine mice exhibiting behavioral deficits and epilepsy. Our results demonstrate that intrahippocampal MGE progenitor transplantation elicits a long-lasting suppression of unprovoked seizures, rescues behavioral deficits, and enhances GABA-mediated synaptic inhibition in epileptic mice. CGE progenitors were not therapeutic in epileptic animals and resulted in abnormal and, in some cases, frank epileptic, electrographic activity in wild-type (WT) animals.
Materials and Methods

Animals
Experiments were done with male adult CD1 mice (http:// www.criver.com/products-services/basic-research/find-a-model/ cd1-e-mouse) housed under a standard 12-hour light cycle with food and water provided ad libitum. Epilepsy was induced by pilocarpine injection as described previously. 14, 26 Briefly, adult (postnatal day [P]50-P60) CD1 mice were first injected with methyl scopolamine (1mg/kg), after 30 minutes pilocarpine (289 mg/kg) was injected intraperitoneally to induce status epilepticus (SE). Injection of pilocarpine produced generalized electrographic activity characterized by high-amplitude, highfrequency paroxysmal discharges consistent with SE 27 (inset in Fig 1A) . Scientific, Waltham, mA) using Fluoroshield solution (F6937; Sigma-Aldrich).
Cell Quantification
Images were obtained with a Leica TCS SP5 confocal or Nikon Eclipse Ni-E epifluorescence microscope. Labeled cells were counted using Fiji (http://imagej.net). Cell quantification was done by t test analysis using GraphPad Prism software (version 7; GraphPad Software Inc., La Jolla, CA). Data are expressed as mean 6 standard error of the mean (SEM).
Behavior
Behavioral tests were done by the Neurobehavioral Core for Rehabilitation Research at UCSF. Briefly, for the open field (OF) test, mice were placed in the center of the arena (Kinder Scientific) and recorded for 10 minutes using a computer operated tracking system (MotorMonitor; Kinder Scientific). Handling test was done as described. 14 Nonstressful handling was performed by rubbing slowly along the back of the mouse in a petting motion in the direction of the grain of fur with a latexgloved hand, and stressful handling was performed by rubbing vigorously against the grain of fur, pinching at the tail tip with a plastic-tipped hemostat, and pinching at the tail base. Each task was performed for 15 seconds. Reaction to handling was scored for each task using a 4-point rating scale in which 1 indicated initial struggle, but calmed within 15 seconds, 2 indicated struggle for more than 15 seconds, 3 indicated struggle for more than 15 seconds and exhibiting one or more defensive reactions (piloerection, flattening of the ears against the head, and attempt to bite or back away from the experimenter), and 4 indicated struggled for more than 15 seconds and exhibited flight behavior (loud vocalization or wild running). Behavioral test analysis was done using GraphPad Prism (version 7; GraphPad Software) software.
Chronic vEEG
Electroencephalographic (EEG) recordings were obtained using a time-locked and tethered vEEG monitoring system (Pinnacle Technologies, Inc., Quezon City, Philippines). Each mouse was anesthetized with ketamine and xylazine (10 and 1mg/kg, intraperitoneal) so that there was no limb-withdrawal response to a noxious foot pinch. Sterile, stainless steel bone screw recording electrodes were placed epidurally through burr holes drilled in the skull (one electrode on either side of the sagittal suture, approximately halfway between bregma and lambda sutures and 1mm from the midline) using surface head-mount EEG hardware (Pinnacle Technologies). Electrodes were cemented in place with a fast-acting adhesive and dental acrylic. Two wires were laid on the shoulder muscles for electromyographic (EMG) recording. Animals were allowed to recover for 5 days before EEG monitoring was initiated. Electrographic seizures were defined as progressive high-frequency (minimum of 5Hz), high-voltage synchronized polyspike or paroxysmal sharp waves with amplitude >2-fold background that lasted for a minimum of 15 seconds. All EEG files were coded and analyzed by an investigator blinded to the recording condition. Electrographic EEG seizures were analyzed using SireniaScore software (Pinnacle Technologies) at 1 minute per frame. All mice included in vEEG analysis were monitored for 14 consecutive days (24 h/ day), for example, a period sufficient to capture at least one seizure cycle. 18, 27 To determine the number of mice necessary for EEG monitoring, a power analysis was performed using SISA software (http://www.quantitativeskills.com/sisa/). Spontaneous seizure frequency for pilocarpine-treated CD1 mice was estimated at 2.4 seizures per day with a standard deviation of 60.46 seizures/day. 14, 26 Using 10% as a value for b (1 -b 5 power or 90%), 0.01 as a value for a, and an expected 80% change in seizure frequency, 14 it is estimated that sample size should be 5 animals per experimental group.
Electrophysiology
Coronal brain slices (300-mm thickness) were prepared from mice at 270 DAT. Mice were deeply anesthetized with ketamine and xylazine (10 mg/kg and 1 mg/kg, intraperitoneal) until unresponsive to toe pinch. Mice were decapitated and brains were submerged into ice-cold oxygenated sucrose cutting solution, containing (in mM): 150 sucrose, 50 NaCl, 25 NaHCO 3 , 10 dextrose, 2.5 KCl, 1 NaH 2 PO 4 , 0.5 CaCl 2 , and 7 MgSO 4 .
Brains were adhered to a cutting platform on a vibratome in this same solution. Slices were then transferred into a holding chamber containing artificial cerebrospinal fluid (ACSF), containing (in mM): 124 NaCl, 26 NaHCO 3 , 10 dextrose, and 3 KCl. The ACSF temperature was held at 358C for 30 minutes, then allowed to equilibrate to room temperature. For recordings, slices were transferred into a recording chamber mounted to an upright microscope (Olympus, Tokyo, Japan) and constantly perfused with oxygenated ACSF. Borosilicate glass patch pipettes (3-5MX) were guided to CA1 pyramidal neurons visually identified under IR-DIC optics. Pipettes contained a cesium chloride-based internal solution for optimal recording of inhibitory postsynaptic currents (IPSCs), containing (in mM): 140 CsCl, 11 EGTA, 10 HEPES, 1 MgCl 2 , 2 ATP-Mg, and 0.5 GTP-Na. After whole-cell configuration was achieved, cells were held at 270mV. Spontaneous IPSCs (sIPSCs) were recorded for a 5-minute epoch. A 5-minute epoch was recorded during which slices were perfused with ACSF containing kynurenic acid (3mM) and tetrodotoxin (0.1 mM) to block glutamatergic synaptic transmission and action potential-mediated IPSCs. Miniature IPSCs (mIPSCs) were then recorded during a third 5-minute epoch. Only cells in which input resistance and holding current were stable were used for data analysis. s-and mIPSCs were analyzed using MiniAnalysis (v6; Synaptosoft, Inc., Fort Lee, NJ) and Prism (v6; GraphPad Software) software.
Statistical Analysis
Data are expressed as mean 6 SEM and compared by repeatedmeasures one-or two-way analysis of variance (ANOVA) with Tukey's multiple comparison test, except as otherwise indicated. Significance in all cases was set at p < 0.05.
Results
MGE Progenitors Transplanted in Adult Epileptic Mice Rescue Behavioral Comorbidities
Adult male CD-1 mice (n 5 134) were administered pilocarpine (P50-P60) to elicit a series of generalized tonic-clonic limbic seizures progressing to SE. 26, 28 After recovering from SE, mice were video monitored for evidence of spontaneous seizure behavior between 10 and 20 days after pilocarpine (n 5 70). Only mice that survived acute SE and were subsequently observed to exhibit at least two unprovoked tonic-clonic seizures of Racine Grade 4 or greater were designated as "epileptic" (n 5 63; 90%) and became candidates for transplantation. The OF test was used to monitor the severity and progression of epilepsy comorbidities in these animals ( Fig 1A) . The first OF test was performed P50 before SE (OF1) with subsequent tests at P80 after the 20th day of postpilocarpine video monitoring, but before transplantation (OF2), and then at P120 (1 DAT; OF3) and P180 (60 DAT; OF4); age-matched na€ ıve male CD-1 mice served as controls at equivalent time points. As expected, 29, 30 epileptic mice exhibited progressive OF behavior deficits compared to controls (Fig 1B1,B2) . Increased time spent in the periphery of the arena was observed at P120 (OF3) and P180 (OF4) for epileptic mice, but not controls (Fig 1B1) . Decreased time standing on their hindlegs (rearing) was also observed at P80 (OF2), P120 (OF3), and P180 (OF4) for epileptic mice, but not controls ( Fig 1B2) . Next, we examined whether MGE cell transplantation could rescue the OF deficit. Epileptic mice receiving bilateral intrahippocampal MGE progenitor cell transplantation (n 5 26) spent significantly less time in the periphery of the arena (Fig 1B3) and showed no change in rearing behavior ( Fig 1B4) . As an additional behavioral evaluation, a handling test was performed. 14 Epileptic mice exhibited increased reaction to handling that was reduced in mice receiving bilateral MGE transplants (Fig 1C) . All epileptic mice displayed aggressive behavior to touch and a "less groomed" overall appearance (Fig 1D) .
MGE Progenitors Transplanted in Adult Epileptic Mice Suppresses Seizure Activity
Our previous studies reported a 92% reduction in electrographic seizures following bilateral intrahippocampal MGE transplantation in epileptic mice starting at 60 DAT. 14 Henderson et al, however, reported a much smaller overall reduction in the total number of spontaneous recurrent seizures following bilateral intrahilar MGE transplantation (35% at 47-67 DAT), and the effect reported was transient with no reduction observed at 68 to 97 DAT. Therefore, to further investigate the long-term disease-modifying effects of intrahippocampal MGE progenitor cell transplantation, adult mice (P300) tested in the OF and handling assays underwent 14 days of continuous vEEG monitoring starting at 180 DAT ( Fig 1A) . Mice were separated into three groups and coded for offline detection of seizures (Fig 2A) by an investigator blind to the status of the experiment: (1) Figure 2A . Electrographic seizures were never observed in na€ ıve mice. Epileptic mice with bilateral intrahippocampal MGE transplantation exhibited an 84% reduction in mean seizure frequency (Fig 2B,C) and an 88% reduction in the total number of seizures detected (Fig. 2D) ; 1 mouse was seizure free during the entire 14-day monitoring period. Transplantation had no effect on seizure duration (Fig 2E) , as reported previously. 14 At 210 DAT, a subset of epileptic mice with bilateral intrahippocampal MGE transplantation, behavioral testing, and EEG monitoring were sacrificed for immunohistochemistry (IHC; Fig 1A; n 5 5). Antibodies recognizing GFP and markers of MGE-derived interneurons (eg, GAD67, PV, SOM, and nNOS) were used to confirm cell identity. Consistent with previous results, 14, 15, 21 we found that GFP 1 MGE cells migrate following transplantation ( Fig 3A) and coexpress neuronal markers such as b3 tubulin (Tuj1) and GAD67 (Fig 3B,C) , as well as PV, SOM, or nNOS (Fig 3D) . To confirm the longlasting integration of MGE-derived interneurons in pilocarpine mice, we processed a separate group of epileptic animals at 12 months after transplantation (360 DAT; n 5 3) and confirmed that GFP 1 MGE cells remain positive for PV, SOM, or nNOS (Fig 3E) . At 270 DAT, a separate pool of na€ ıve (n 5 6), untreated epileptic (n 5 7), and epileptic mice receiving bilateral intrahippocampal MGE progenitor cell transplantation (n 5 6) previously tested on behavioral and EEG assays were sacrificed for slice electrophysiology. To confirm a functional enhancement of GABA-mediated inhibition, 11, 16, 17 we obtained voltage-clamp recordings from pyramidal neurons in regions of hippocampus containing GFP 1 cells. CA1 pyramidal neurons were held at -70mV and sIPSC and mIPSC, respectively, was measured ( Fig 4A) . By one-way ANOVA followed by Tukey's multiple comparisons test (p 5 0.0011), event frequency was significantly reduced for sIPSCs in epileptic animals compared with na€ ıve, as previously reported 28 (na€ ıve:
9.36 6 1.15Hz, n 5 6 cells; pilocarpine: 3.62 6 0.69Hz, n 5 14 cells), but restored to levels comparable to agematched na€ ıve controls in epileptic mice receiving intrahippocampal MGE cells (MGE: 6.86 6 1.14Hz, n 5 9 cells; Fig 4B) . Similar statistically significant reductions (p 5 0.0135) were observed for mIPSC frequency (na€ ıve: 7.79 6 1.84Hz, n 5 6 cells; pilocarpine: 3.09 6 0.84Hz; n 5 12 cells) and restored to levels comparable to agematched na€ ıve controls in epileptic mice receiving intrahippocampal MGE cells (MGE: 7.65 6 1.42, n 5 6 cells; Fig 4E) . No change in sIPSC decay tau kinetics (p 5 0.296; Fig 4C) CGE Progenitor Transplantation Is Not Therapeutic in Mice CGE progenitors transplanted into adult mouse hippocampus also migrate and integrate as GABAergic neurons. 12, 13 In contrast to MGE, CGE transplanted progenitors primarily differentiate to CR-, VIP-, and reelin-positive interneuron subpopulations shown to form functional synapses with excitatory and inhibitory neurons. Here, we investigated the transplantation of CGE progenitors in adult mice using Nkx2.1-Cre;R26-GDTA donor embryos to genetically ablate MGEderived interneurons. 13, 31 We followed two transplant strategies: (1) intrahippocampal transplantation into WT neonatal mice to evaluate CGE progenitors in healthy animals and (2) intrahippocampal transplantation into adult epileptic mice to evaluate potential therapeutic effects (Fig 5A) . CGE-derived neurons from Nkx2.1-Cre;R26-GDTA donor mice contain virtually no PV or SOM interneurons, 13 but coexpress VIP ( Fig   5A) . At 30 DAT, we observed brief "interictal" bursts lasting 2 to 5 seconds in duration in all CGEtransplanted mice (n 5 3; Fig 5B) . At 90 DAT, EEG events with high-frequency, high-voltage, rhythmic activity with clear onset, progression, and termination were observed in all mice (n 5 3; Fig 5B) . Next, a separate group of adult epileptic mice (P50) receiving bilateral CGE progenitor cell transplantation underwent 14 days of continuous vEEG monitoring starting at 60 DAT (n 5 5). In stark contrast to epileptic mice receiving MGE progenitor cells (Fig 3) , the pattern and frequency of electrographic seizure activity did not diminish (Fig 5C,D) frequency around 8Hz (Fig 6A,B) . These oscillations were not associated with any overt behaviors or EMG activity. Analysis of a random sampling of 100 oscillatory events per animal group showed that the duration of these events was similar in all mice (Fig 6C) . These oscillatory events, though greater than 2 seconds in duration, characterized by an abrupt onset and termination, and appearing to be both high-amplitude and rhythmic, were not classified as seizures or considered pathological. 
Discussion
We found that MGE progenitor cells transplanted into the hippocampus of adult epileptic mice exert a longlasting therapeutic effect. Studies described here were performed between 1 and 12 months after transplantation in a well-characterized, clinically relevant mouse model of acquired epilepsy. 29, [32] [33] [34] These studies independently confirm and significantly extend our earlier report of seizure suppression and rescue of behavioral comorbidities in this model starting at 2 months after transplantation using MGE progenitors. 14 We also showed, for the first time, that CGE progenitors transplanted into the hippocampus of adult animals lead to abnormal electrographic seizure-like activity in healthy mice, but have no effect on seizure activity in epileptic mice. Although our primary goal was to demonstrate an effect of MGE progenitor cell transplantation on spontaneous recurrent seizures, the pilocarpine model used here also exhibits well-established behavioral comorbidities. [32] [33] [34] Temporal lobe epilepsy patients exhibit comorbidities, such as cognitive decline, anxiety, and depression. 35 Whereas seizure control is an important consideration in the treatment of these patients, a therapy that also modifies comorbidities would be of great value. Epileptic pilocarpine-treated mice allowed us to efficiently study both issues in a preclinical research setting. Unlike other studies putatively designed to analyze the effects of cell transplantation on epilepsy comorbidities, 36, 37 we first confirmed a seizure phenotype in all test animals using continuous video monitoring following pilocarpine-induced SE. With this strategy, we avoid transplanting mice that recover from SE and remain seizure free, 30 thus maintaining an experimental protocol analogous to the clinical situation wherein a patient would seek treatment after the emergence of spontaneous recurrent seizures. Once identified as epileptic, mice were periodically monitored for OF and handling deficits. 29, 32, 34 Consistent with previous studies, 29, 30 epileptic pilocarpine-treated mice progressively spent less time in the unprotected open environment section of the arena. Monitoring OF and handling behavior in epileptic mice receiving MGE progenitor cells, and age-matched controls, we observed a rescue of these behaviors that persisted to 60 DAT, as reported previously. 14 Most important, following these animals to 180 DAT and using a 2-week 24/7 vEEG monitoring period, we observed an 84% reduction in mean seizure frequency and an 88% reduction in the total number of seizures. Given that we assessed animals around 250 to 280 days after pilocarpine-induced SE, and in mice with verified epilepsy and behavioral deficits, it seems plausible to conclude that MGE progenitor cell transplantation has significant and long-lasting benefits. Additionally, when the identity of transplanted cells was confirmed in these animals at 210 DAT, we noted that neurons were GABAergic and expressed markers (SOM, PV, and nNOS) consistent with an MGE lineage. 4, 6, 10, 11 A similar expression pattern was observed 12 months after transplantation, further confirming stable long-term integration of MGE-derived interneurons in the host brain (see Fig 3E) . Although most GFP-positive neurons colabeled with an antibody to the GABA-synthesizing enzyme, GAD67, these cell counts may underestimate the true number of MGE-derived GABAergic interneurons because (1) tissue for these studies was processed from adult mice undergoing various procedures that could impact activitydependent enzyme levels, and (2) GAD67 expression was confirmed in only 75% of GFP-expressing cells in studies using GAD67-GFP mice. 51 It has previously been shown that IPSC frequency, a physiological measure of GABAmediated inhibition, is enhanced 20% to 40% in regions containing MGE progenitor-derived interneurons. 11, 15, 17, 38 This increase would be expected to enhance interneuron-mediated "surround inhibition" in the epileptic hippocampi [39] [40] [41] and provides the most parsimonious explanation for seizure suppression observed with MGE progenitors. Consistent with this mechanistic interpretation, we initially observed a decrease in IPSC frequency in epileptic mice comparable to that reported previously, 28, 42, 43 and then an increase of miniature and spontaneous IPSCs back toward control levels in mice receiving MGE progenitor cells. Although sample sizes are relatively modest for adult slice electrophysiology experiments, the small variability and statistical significance of these findings are consistent with this interpretation. Future studies using optogenetics 19 or dual-patch recordings 16 will be necessary to more fully evaluate integration of MGE-derived interneurons in epileptic animals. Taken together, these functional studies demonstrate that transplanted interneurons integrate into neural circuits affected by epilepsy and argue against earlier suggestions that transplanted interneurons may lose their ability to establish inhibitory synapses, weaken endogenous inhibition, or elicit functional reorganization in the host brain. 18, 44, 45 Given that these electrophysiology studies were performed at 270 DAT in mice already confirmed to exhibit handling and OF behaviors comparable to controls, as well as a significant reduction in electrographic seizures, they provide direct preclinical evidence that transplanted MGE-derived interneurons integrate into neural networks affected by long-standing epilepsy where they exert a long-lasting effect on seizure phenotypes and comorbidities. Although it has been suggested that seizure suppressive effects of MGE progenitor cell transplantation may be transient, 18, 25 here starting at 180 DAT, and in our earlier publications at 45 and 60 DAT, 14, 17 we have found absolutely no evidence to support this conclusion. There are at least two potential explanations for this discrepancy. First, in Henderson et al, 18 MGE cell transplantation occurred 2 weeks after pilocarpine-induced SE in mice that were not monitored for the emergence of an epileptic phenotype. Because of the variability inherent in this acquired epilepsy model, 30, 46 some pilocarpinetreated mice will never progress to exhibit spontaneous recurrent seizures, making it possible that Henderson et al 18 MGE treatment groups, which used a milder form of initial SE and then failed to monitor post-SE animals to confirm a seizure phenotype before transplantation, include mice that were not epileptic. 30, 33, 34 In contrast, our studies utilize continuous 24-hour video premonitoring to confirm seizure phenotype during the latent period in all pilocarpine-treated SE animals before inclusion into treatment (or control) groups, followed by a progressive monitoring of epilepsy behavioral comorbidities. Second, our protocol utilizes bilateral transplantation of freshly dissociated MGE cells (suspended in Leibovitz L-15 medium) into four intrahippocampal sites to achieve wide distribution of new inhibitory interneurons at multiple locations. 14 Henderson et al 18 used bilateral transplantation of MGE cells (transfected with a neural stem cell nucleofector kit and preincubated in media containing growth factors) into a single hilar site in the dentate gyrus. Freshly harvested or in toto cryopreserved MGE progenitors have significantly better cell viability and migratory properties than growth-factortreated preparations, 47 and this protocol difference, combined with a single injection site strategy, may contribute to the relatively small area of new interneuron integration observed in Henderson et al. 18 Given the widespread hippocampal damage and circuit reorganization characteristic of the systemic pilocarpine model, 29, [32] [33] [34] it would be difficult to achieve a significant therapeutic effect with such a limited distribution of MGE-derived interneurons. Because interneurons derived from the CGE can migrate and integrate when transplanted in the neonatal or adult brain, 12, 13, 48 we also tested whether CGE progenitors could be beneficial for epilepsy therapy. Given that small numbers of migrating MGE progenitors can contaminate anatomical CGE transplants, 48 we used a genetic manipulation to ablate Nkx2.1 1 MGE progenitor cells from our CGE transplants. 13 This strategy was recently used to demonstrate CGE-derived interneurons integrate as primarily VIP-, CR-, or reelin-positive interneurons, but do not induce cortical plasticity. 13 Here, we showed that healthy WT mice receiving CGE progenitors at P2 began to exhibit abnormal network excitability as early as 30 DAT and frank seizure-like electrographic activity by 60 DAT. Moreover, when CGE progenitors were transplanted into adult epileptic mice, we failed to detect any suppression of seizure activity. Because CGEderived interneuron subtypes include those that can form functional inhibitory synapses onto inhibitory neurons (ie, VIP-or CR-expressing cells), 6 ,13 the additional CGE-derived neurons could result in disinhibition. In a WT mouse, new CGE-derived interneurons would increase inhibitory tone onto fast-spiking and nonadapting, non-fast-spiking inhibitory neurons that innervate excitatory neurons, resulting in reduced inhibitory-toexcitatory neuron function, a disinhibitory microcircuit and generation of abnormal electrographic activity (see Fig 5B) . In an epileptic hippocampus with reduced inhibitory-to-excitatory neuron connections, these CGEderived, interneuron-innervating interneurons and the additional disinhibition would not serve to reduce abnormal levels of excitability associated with epilepsy (see Fig  5C) . In contrast, MGE-derived interneuron subtypes include those that are strategically located to control excitatory neuron spiking and burst firing (ie, PV-and SOM-expressing cells), 6 thus acting to enhance inhibitory tone in epileptic animals (see Fig 4) and suppress seizures (see Fig 2) . Taken together, these findings suggest that "MGE-like" interneurons generated from human embryonic or induced pluripotent stem cells containing significant fractions of VIP-or CR-positive, CGE-like interneurons 49, 50 are not appropriate for cell-therapybased applications in epilepsy. We conclude that MGE, but not CGE, progenitor cell transplantation is associated with a long-lasting therapeutic effect in preclinical epilepsy models. Highlighting the importance of an appropriate disease model, interneuron location, distribution, and subpopulation identity in understanding the therapeutic potential of progenitor cell transplantation.
